tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Impact BioMedical Finalizes Debt Conversion Agreement

Story Highlights
Impact BioMedical Finalizes Debt Conversion Agreement

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Impact BioMedical, Inc. ( (IBO) ) is now available.

On July 21, 2025, Impact BioMedical Inc. entered into a Debt Conversion Agreement with DSS, Inc. to settle a $12 million loan originally made in March 2023. The agreement involves the issuance of 31,939,778 shares of common stock to DSS, fully satisfying the debt and any additional financial support provided by DSS up to the transaction’s closing.

More about Impact BioMedical, Inc.

Average Trading Volume: 11,314,788

Technical Sentiment Signal: Strong Sell

For an in-depth examination of IBO stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1